Authors: BRADY EM WELLS DS KIERSTEAD AE MUELLER AL NEWMAN MK SANGUINETTI EL MARRIOTT TB WESTON I

Citation: Em. Brady et al., ASCENDING DOSE SAFETY AND PHARMACOKINETIC TRIAL OF NPS-1506, A NOVEL NMDA RECEPTOR ANTAGONIST, IN NORMAL-MALE VOLUNTEERS, Neurology, 50(4), 1998, pp. 49004-49004

Authors: SILVERBERG SJ BONE HG MARRIOTT TB LOCKER FG THYSJACOBS S DZIEM G KAATZ S SANGUINETTI EL BILEZIKIAN JP

Citation: Sj. Silverberg et al., SHORT-TERM INHIBITION OF PARATHYROID-HORMONE SECRETION BY A CALCIUM-RECEPTOR AGONIST IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM, The New England journal of medicine, 337(21), 1997, pp. 1506-1510

Authors: SILVERBERG SJ THYSJACOBS S LOCKER FG SANGUINETTI EL MARRIOTT TB BILEZIKIAN JP

Citation: Sj. Silverberg et al., THE EFFECT OF THE CALCIMIMETIC DRUG NPS R-568 ON PARATHYROID-HORMONE SECRETION IN PRIMARY HYPERPARATHYROIDISM, Journal of bone and mineral research, 11, 1996, pp. 87-87